Cargando…

Evaluation of limited blood sampling population input approaches for kinetic quantification of [(18)F]fluorothymidine PET data

BACKGROUND: Quantification of kinetic parameters of positron emission tomography (PET) imaging agents normally requires collecting arterial blood samples which is inconvenient for patients and difficult to implement in routine clinical practice. The aim of this study was to investigate whether a pop...

Descripción completa

Detalles Bibliográficos
Autores principales:	Contractor, Kaiyumars B, Kenny, Laura M, Coombes, Charles R, Turkheimer, Federico E, Aboagye, Eric O, Rosso, Lula
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer 2012
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3340309/ https://www.ncbi.nlm.nih.gov/pubmed/22444834 http://dx.doi.org/10.1186/2191-219X-2-11

Ejemplares similares

Synthesis and evaluation of 3′-[(18)F]fluorothymidine-5′-squaryl as a bioisostere of 3′-[(18)F]fluorothymidine-5′-monophosphate
por: Brickute, D., et al.
Publicado: (2021)

(18)F-fluorothymidine PET imaging in gliomas: an update
por: Nikaki, Alexandra, et al.
Publicado: (2017)

Monitoring Response to Transarterial Chemoembolization in Hepatocellular Carcinoma Using (18)F-Fluorothymidine PET
por: Sharma, Rohini, et al.
Publicado: (2020)

(18)F-fluorothymidine PET for predicting survival in patients with resectable pancreatic cancer
por: Wieder, Hinrich, et al.
Publicado: (2018)

Evaluation of (18)F-fluorothymidine positron emission tomography ([(18)F]FLT-PET/CT) methodology in assessing early response to chemotherapy in patients with gastro-oesophageal cancer
por: Sharma, R., et al.
Publicado: (2016)

In vivo imaging of cellular proliferation in renal cell carcinoma using 18F-fluorothymidine PET
por: Wong, Peter K., et al.
Publicado: (2014)

Preliminary clinical assessment of the relationship between tumor alphavbeta3 integrin and perfusion in patients studied with [(18)F]fluciclatide kinetics and [(15)O]H(2)O PET
por: Kenny, Laura M, et al.
Publicado: (2014)

Preclinical Applications of 3'-Deoxy-3'-[(18)F]Fluorothymidine in Oncology - A Systematic Review
por: Schelhaas, Sonja, et al.
Publicado: (2017)

[(18)F]Fluorothymidine PET imaging in the diagnosis of leptomeningeal involvement with diffuse large B-cell lymphoma
por: Holter, Jennifer L., et al.
Publicado: (2011)

[(18)F]fluorothymidine and [(18)F]fluorodeoxyglucose PET Imaging Demonstrates Uptake and Differentiates Growth in Neurofibromatosis 2 Related Vestibular Schwannoma
por: Anton-Rodriguez, Jose M., et al.
Publicado: (2019)

Evaluation of the Performance of 18F-Fluorothymidine Positron Emission Tomography/Computed Tomography (18F-FLT-PET/CT) in Metastatic Brain Lesions
por: Nikaki, Alexandra, et al.
Publicado: (2019)

Early Response Assessment to Targeted Therapy Using 3′-deoxy-3′[(18)F]-Fluorothymidine ((18)F-FLT) PET/CT in Lung Cancer
por: Kairemo, Kalevi, et al.
Publicado: (2020)

(18)F-Fluorothymidine-Pet Imaging of Glioblastoma Multiforme: Effects of Radiation Therapy on Radiotracer Uptake and Molecular Biomarker Patterns
por: Chandrasekaran, Sanjay, et al.
Publicado: (2013)

A Subset of Non-Small Cell Lung Cancer Patients Treated with Pemetrexed Show (18)F-Fluorothymidine “Flare” on Positron Emission Tomography
por: Aravind, Preetha, et al.
Publicado: (2023)

18 F-fluorothymidine uptake in follicular lymphoma and error-prone DNA repair
por: Wondergem, Marielle J, et al.
Publicado: (2014)

Pilot study assessing (18)F-fluorothymidine PET/CT in cervical and vaginal cancers before and after external beam radiation()
por: Cho, Linda P., et al.
Publicado: (2015)

Automatic derivation of an MR-PET image-based input function for quantification of 18F-FET
por: da Silva, Nuno Andre, et al.
Publicado: (2015)

The Influence of Interpreters’ Professional Background and Experience on the Interpretation of Multimodality Imaging of Pulmonary Lesions Using( 18)F-3′-Deoxy-Fluorothymidine and (18)F-Fluorodeoxyglucose PET/CT
por: Xu, Bai-xuan, et al.
Publicado: (2013)

Molecular Imaging with 3′-deoxy-3′[(18)F]-Fluorothymidine ((18)F-FLT) PET/CT for Early Response to Targeted Therapies in Sarcomas: A Pilot Study
por: Kairemo, Kalevi, et al.
Publicado: (2020)

Mismatched intratumoral distribution of [(18)F] fluorodeoxyglucose and 3′-deoxy-3′-[(18)F] fluorothymidine in patients with lung cancer
por: Wang, Xiangcheng, et al.
Publicado: (2017)

Mismatched intratumoral distribution of [18F] fluorodeoxyglucose and 3′-deoxy-3′-[18F] fluorothymidine in patients with lung cancer
por: Wang, Xiangcheng, et al.
Publicado: (2018)

(18)F-Fluorothymidine PET-CT for Resected Malignant Gliomas before Radiotherapy: Tumor Extent according to Proliferative Activity Compared with MRI
por: Zhao, Fen, et al.
Publicado: (2015)

(18)F-fluorodeoxyglucose (FDG) PET or (18)F-fluorothymidine (FLT) PET to assess early response to aromatase inhibitors (AI) in women with ER+ operable breast cancer in a window-of-opportunity study
por: Romine, Perrin E., et al.
Publicado: (2021)

PET quantification of [(18)F]MPPF in the canine brain using blood input and reference tissue modelling
por: Pauwelyn, Glenn, et al.
Publicado: (2019)

Phosphorylation Status of Thymidine Kinase 1 Following Antiproliferative Drug Treatment Mediates 3′-Deoxy-3′-[(18)F]-Fluorothymidine Cellular Retention
por: Sala, Roberta, et al.
Publicado: (2014)

[(18)F]Fluorothymidine Uptake in the Porcine Pancreatic Elastase-Induced Model of Abdominal Aortic Aneurysm
por: Gandhi, Richa, et al.
Publicado: (2021)

Diagnostic value of PET/CT with (11)C-methionine (MET) and (18)F-fluorothymidine (FLT) in newly diagnosed glioma based on the 2016 WHO classification
por: Ogawa, Tomoya, et al.
Publicado: (2020)

(18)F-fluorothymidine (FLT)-PET and diffusion-weighted MRI for early response evaluation in patients with small cell lung cancer: a pilot study
por: Christensen, Tine Nøhr, et al.
Publicado: (2020)

Noninvasive quantification of cerebral metabolic rate for glucose in rats using (18)F-FDG PET and standard input function
por: Hori, Yuki, et al.
Publicado: (2015)

Comparison of 4′-[methyl-(11)C]thiothymidine ((11)C-4DST) and 3′-deoxy-3′-[(18)F]fluorothymidine ((18)F-FLT) PET/CT in human brain glioma imaging
por: Toyota, Yasunori, et al.
Publicado: (2015)

Exploratory Analysis of (18)F-3’-deoxy-3’-fluorothymidine ((18)F-FLT) PET/CT-Based Radiomics for the Early Evaluation of Response to Neoadjuvant Chemotherapy in Patients With Locally Advanced Breast Cancer
por: Fantini, Lorenzo, et al.
Publicado: (2021)

(18)F-Fluorothymidine PET is an early and superior predictor of progression-free survival following chemoimmunotherapy of diffuse large B cell lymphoma: a multicenter study
por: Minamimoto, Ryogo, et al.
Publicado: (2021)

Prognostic Impact of [18F]Fluorothymidine and [18F]Fluoro-D-Glucose Baseline Uptakes in Patients with Lung Cancer Treated First-Line with Erlotinib
por: Scheffler, Matthias, et al.
Publicado: (2013)

Comparison of (18)F-fluorothymidine Positron Emission Tomography/Computed Tomography and (18)F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Breast Cancer
por: Mori, Mio, et al.
Publicado: (2022)

Toxicology evaluation of radiotracer doses of 3'-deoxy-3'-[(18)F]fluorothymidine ((18)F-FLT) for human PET imaging: Laboratory analysis of serial blood samples and comparison to previously investigated therapeutic FLT doses
por: Turcotte, Eric, et al.
Publicado: (2007)

An Assessment of Early Response to Targeted Therapy via Molecular Imaging: A Pilot Study of 3′-deoxy-3′[(18)F]-Fluorothymidine Positron Emission Tomography (18)F-FLT PET/CT in Prostate Adenocarcinoma
por: Kairemo, Kalevi, et al.
Publicado: (2017)

Relative skeletal distribution of proliferating marrow in the adult dog determined using 3′‐deoxy‐3′‐[(18)F]fluorothymidine
por: Rowe, Joshua A., et al.
Publicado: (2018)

Image-Derived Input Functions for Quantification of A(1) Adenosine Receptors Availability in Mice Brains Using PET and [(18)F]CPFPX
por: He, Xuan, et al.
Publicado: (2020)

3′-Deoxy-3′-[(18)F]-Fluorothymidine PET Imaging Reflects PI3K-mTOR-Mediated Pro-Survival Response to Targeted Therapy in Colorectal Cancer
por: McKinley, Eliot T., et al.
Publicado: (2014)

Evaluation of diffusion-weighted MRI and (18F) fluorothymidine-PET biomarkers for early response assessment in patients with operable non-small cell lung cancer treated with neoadjuvant chemotherapy
por: Carlin, Dominic, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ulvc3vske14oenfstc3rvv0jit